SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $767,284 | -81.2% | 6,700 | -78.7% | 0.05% | -79.7% |
Q4 2022 | $4,081,770 | +20.3% | 31,500 | +2.6% | 0.23% | +45.3% |
Q3 2022 | $3,393,000 | +639.2% | 30,701 | +397.1% | 0.16% | +783.3% |
Q1 2021 | $459,000 | -96.6% | 6,176 | -92.2% | 0.02% | -96.5% |
Q4 2020 | $13,582,000 | +115.4% | 79,668 | +77.4% | 0.52% | +74.5% |
Q3 2020 | $6,306,000 | +9.2% | 44,900 | +24.7% | 0.30% | -8.9% |
Q2 2020 | $5,773,000 | +780.0% | 36,000 | +437.5% | 0.33% | +528.8% |
Q1 2020 | $656,000 | -89.5% | 6,698 | -86.2% | 0.05% | -84.9% |
Q4 2019 | $6,244,000 | +143.1% | 48,400 | +41.9% | 0.34% | +109.1% |
Q3 2019 | $2,569,000 | +128.6% | 34,100 | +360.8% | 0.16% | +153.8% |
Q2 2019 | $1,124,000 | -37.5% | 7,400 | -51.0% | 0.06% | -39.8% |
Q1 2019 | $1,799,000 | -3.0% | 15,100 | -11.2% | 0.11% | -12.9% |
Q4 2018 | $1,855,000 | -32.4% | 17,000 | 0.0% | 0.12% | +6.0% |
Q3 2018 | $2,746,000 | +22.2% | 17,000 | 0.0% | 0.12% | +11.4% |
Q2 2018 | $2,247,000 | +78.3% | 17,000 | 0.0% | 0.10% | +66.7% |
Q1 2018 | $1,260,000 | +33.2% | 17,000 | 0.0% | 0.06% | +34.0% |
Q4 2017 | $946,000 | – | 17,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |